References
- Kannel WB, Sorlie P. Hypertension in Framingham. Paul O. Epidemiology and control of hypertension. F Miami, Symposia Specialists, 1975. 553–592.
- Afonso LC, Edelson GW, Sowers JR. Metabolic abnormalities in hypertension. Curr Opin Nephrol Hypertens. 1997;6: 219–223.
- Gaziano JM, Sesso HD, Breslow JL, Hennekens CH, Buring JE. Relation between systemic hypertension and blood lipids on the risk of myocardial infarction. Am J Cardiol. 1999; 84:768–773.
- Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003;139:761–776.
- Rubba P, Mancini M. Lipid-lowering treatment: Effects on endothelial dysfunction. Curr Opin Lipidol. 1995;6: 348–353.
- Kool M, Lustermans F, Kragten H, . Does lowering of cholesterol levels influence functional properties of large arteries? Eur J Clin Pharmacol. 1995;48:217–223.
- Pearson TA, Swan HJ. Lipid lowering: The case for identifying and treating the high-risk patient. Cardiol Clin. 1996; 14:117–130.
- Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652–662.
- Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997–1000.
- Schaeffner ES, Kurth T, Curhan GC, . Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14:2084–2091.
- Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension: Parallels between human disease and rodent models. Diabetes Care. 1991;14:195–202.
- Zavaroni I, Mazza S, Dall'Aglio E, Gasparini P, Passeri M, Reaven GM. Prevalence of hyperinsulinemia in patients with high blood pressure. J Intern Med. 1992;231:235–240.
- Huang CQ, Dong BR, Zhang YL, Wu HM, Liu QX, Flaherty JH.Cognitive impairment and hypertension among Chinese nonagenarians and centenarians. Hypertens Res. 2009;32: 554–558.
- Huang CQ, Dong BR, Wu HM, Zhang YL. Association of cognitive impairment with serum lipid/lipoprotein among Chinese nonagenarians and centenarians. Dementia Geriatric Cogn Dis. 2009;27:111–116.
- Prinz PN. Age impairments in sleep, metabolic and immune functions. Exp Gerontol. 2004;39:1739–1743.
- Castelli WP, Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med. 1986;80:23–32.
- Me Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR. Concordance for dyslipidemic hypertension in male twins. JAMA. 1991;265:2079–2084; d. 1986;80: 23–32.
- Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR. Concordance for dyslipidemic hypertension in male twins. JAMA. 1991;265:2079–2084.
- Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension. 1991;17:969–976.
- Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006; 47:45–50.